Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

BACKGROUND AND PURPOSE: Pancreatic cancer is a highly aggressive malignancy, and improvement in systemic therapy is necessary to treat this frequently encountered metastatic disease. The current targeted agents used in combination with gemcitabine improved objective response rates, but with little o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Iwanski, Gabriela B, Lee, Dhong H, En-Gal, Shlomit, Doan, Ngan B, Castor, Brandon, Vogt, Marco, Toh, Melvin, Bokemeyer, Carsten, Said, Jonathan W, Thoennissen, Nils H, Koeffler, H Phillip
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2010
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936004/
https://ncbi.nlm.nih.gov/pubmed/20590594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2010.00741.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados